These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18714393)

  • 1. Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.
    Okazaki T; Ebihara S; Asada M; Yamanda S; Niu K; Arai H
    Neoplasia; 2008 Sep; 10(9):932-9. PubMed ID: 18714393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
    Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
    Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor α primes cerebral endothelial cells for erythropoietin-induced angiogenesis.
    Wang L; Chopp M; Teng H; Bolz M; Francisco MA; Aluigi DM; Wang XL; Zhang RL; Chrsitensen S; Sager TN; Szalad A; Zhang ZG
    J Cereb Blood Flow Metab; 2011 Feb; 31(2):640-7. PubMed ID: 20700128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin receptor contributes to melanoma cell survival in vivo.
    Kumar SM; Zhang G; Bastian BC; Arcasoy MO; Karande P; Pushparajan A; Acs G; Xu X
    Oncogene; 2012 Mar; 31(13):1649-60. PubMed ID: 21860424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin promotes hair shaft growth in cultured human hair follicles and modulates hair growth in mice.
    Kang BM; Shin SH; Kwack MH; Shin H; Oh JW; Kim J; Moon C; Moon C; Kim JC; Kim MK; Sung YK
    J Dermatol Sci; 2010 Aug; 59(2):86-90. PubMed ID: 20554434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.
    Yang J; Xiao Z; Li T; Gu X; Fan B
    Int J Oncol; 2012 Apr; 40(4):1230-7. PubMed ID: 22086127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
    Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
    Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
    Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
    Hardee ME; Cao Y; Fu P; Jiang X; Zhao Y; Rabbani ZN; Vujaskovic Z; Dewhirst MW; Arcasoy MO
    PLoS One; 2007 Jun; 2(6):e549. PubMed ID: 17579721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.
    Wu P; Zhang N; Wang X; Zhang C; Li T; Ning X; Gong K
    PLoS One; 2012; 7(9):e45122. PubMed ID: 23028796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
    Chan KK; Matchett KB; Coulter JA; Yuen HF; McCrudden CM; Zhang SD; Irwin GW; Davidson MA; Rülicke T; Schober S; Hengst L; Jaekel H; Platt-Higgins A; Rudland PS; Mills KI; Maxwell P; El-Tanani M; Lappin TR
    Oncotarget; 2017 Jun; 8(24):38251-38263. PubMed ID: 28418910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin stimulates melanoma tumor growth through activation of initiation factor eIF4E.
    Julius A; Desai A; Yung RL
    Oncotarget; 2017 May; 8(18):30317-30327. PubMed ID: 28415825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
    Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
    Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised?
    Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M
    Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin in tumor angiogenesis.
    Annese T; Tamma R; Ruggieri S; Ribatti D
    Exp Cell Res; 2019 Jan; 374(2):266-273. PubMed ID: 30576679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
    Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
    Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
    Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
    World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
    Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
    J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.